lobbying_activities: 1374703

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1374703	831d177d-15d3-45d6-8dfb-b71e3e1e8dc0	Q1	CAPITOL HILL CONSULTING GROUP	72053	PURDUE PHARMA LLP	2013	first_quarter	PHA	Controlled Drug Substances Act (21 USC 13) Stop Oxy Abuse Act Stop Tampering of Prescription Pills Act of 2013 (H.R. 486)	HOUSE OF REPRESENTATIVES,SENATE	47000		0	0	2013-04-17T12:34:47.713000-04:00